Brazil top court gives nod for probe into Bolsonaro over vaccine deal

The president has been implicated in allegations of irregularities surrounding a 1.6 billion reais ($316 million) contract signed in February for 20 million doses

Jair Bolsonaro
Jair Bolsonaro, Brazil's president, pauses while speaking during a news conference at the Planalto Palace in Brasilia, Brazil, on Wednesday, March 31, 2021. (Photo: Bloomberg)
Reuters Sao Paulo
2 min read Last Updated : Jul 03 2021 | 8:41 PM IST
Brazil's Supreme Court Justice Rosa Weber late on Friday authorized an investigation of President Jair Bolsonaro by the top prosecutor's office, or PGR, for dereliction of duty in the process of procuring an Indian COVID-19 vaccine, according to a copy of the decision seen by Reuters.
 
The president has been implicated in allegations of irregularities surrounding a 1.6 billion reais ($316 million) contract signed in February for 20 million doses with a Brazilian intermediary for the vaccine's maker, Bharat Biotech.
 
A Brazilian Senate commission investigating the administration's handling of the pandemic has cited suspicions of overpricing and corruption related to the contract. After allegations of irregularities surfaced, the government suspended the contract.
Brazil has suffered the world's second highest number of COVID-19 deaths.
 
Brazilian federal prosecutors and the comptroller general's office, or CGU, are also separately investigating the alleged irregularities in the deal. The case allegedly involves the government's chief whip in the lower house of Congress, Ricardo Barros, according to lawmakers.
 
Bolsonaro and Barros denied any wrongdoing.
 
The investigation of the president by the PGR had to be formally authorized by the Supreme Court. In her decision, Justice Weber gave authorities 90 days for collection of evidence pertaining to the case.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusBrazil

Next Story